Marc Lenburg, PhD
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Computational Biomedicine

PhD, University of California San Francisco
BA, Wesleyan University

Pronouns: he/him/his



Expertise in computational approaches to leverage genome-wide datasets (especially genome-wide gene-expression) for clinical and biological insight. Interests include developing and applying these tools for translational research.

Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine


Member
Boston University
BU-BMC Cancer Center


Member
Boston University
Pulmonary Center


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Member
Boston University
Genome Science Institute


Member
Boston University
Bioinformatics Graduate Program


Graduate Medical Sciences Educator and Mentor (Primary Mentor of Graduate Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma
07/10/2023 - 06/30/2028 (PI)
NIH/National Cancer Institute
5R01CA275015-03

The Boston University - UCLA Lung Cancer Biomarker Characterization Center
09/01/2022 - 07/31/2027 (Multi-PI)
PI: Marc Lenburg, PhD
NIH/National Cancer Institute
5U2CCA271898-04

Sequencing of nasal RNA from individuals at high risk for lung cancer
01/01/2023 - 12/31/2026 (PI)
Inova Health Care Services


RNA sequencing and data processing of nasal epithelium samples from never-smoking women in Guatemala
09/13/2025 - 09/12/2026 (PI)
NIH/National Cancer Institute


EXCAMP – effect of military exposures on airway gene expression and molecular modifiers of lung cancer among military personnel
10/15/2025 - 06/30/2026 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. USU Federal Med Sch


The Boston University Clinical and Transitional Science Institute
04/15/2020 - 03/31/2026 (Key Person)
PI: Megan H. Bair-Merritt, MD, MSCE
NIH/National Center for Advancing Translational Sciences
5UL1TR001430-09

EXCAMP -- effect of military exposures on airway gene expression and molecular modifiers of lung cancer among military personnel
07/01/2024 - 01/31/2026 (Subcontract PI)
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. USU Federal Med Sch


mRNA expression sequencing analysis of nasal swabs from workers exposed to electronic waste processing in Accra, Ghana
07/15/2025 - 09/20/2025 (Subcontract PI)
Westat, Inc. NIH NCI
75N91022D00006

Data sample and extraction, sequencing, and QC on samples from the GWAS replication lung cancer study
09/01/2024 - 08/31/2025 (PI)
NIH/National Cancer Institute


The American Lung Association (ALA) Lung Health Cohort
06/15/2019 - 06/30/2025 (Subcontract PI)
Northwestern University NIH NHLBI
5U01HL146408-06

Showing 10 of 24 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2025 Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma 5R01CA275015-03
2025 Admin Core 5U2CCA271898-04-6879
2025 The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-04
2024 Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma 5R01CA275015-02
2024 Admin Core 5U2CCA271898-03-6879
2024 The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-03
2023 Integrating imaging and biopsy-derived molecular markers for the pre-surgical detection of indolent and aggressive early stage lung adenocarcinoma 1R01CA275015-01A1
2023 Admin Core 5U2CCA271898-02-6879
2023 The Boston University - UCLA Lung Cancer Biomarker Characterization Center 5U2CCA271898-02
2022 Admin Core 1U2CCA271898-01-5084
Showing 10 of 49 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Anderson KE, Tran LM, Krysan K, Kefella Y, Yu L, Fishbein GA, Rodriguez EF, Shabihkhani M, Stefanko DP, Green E, Liu G, Liu H, Zhang S, Kane E, Mehrad M, Spira AE, Dubinett SM, Burks EJ, Mazzilli SA, Lenburg ME, Beane JE. Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease. Mol Cancer Res. 2026 May 06.View Related Profiles. PMID: 42089783; DOI: 10.1158/1541-7786.MCR-25-1093;
     
  2. Souery W, Wong J, Diaz AA, Xu K, Xiao X, Liu H, Liu G, Gower AC, Alekseyev YO, Billatos E, Lenburg ME. Validation of bronchial airway gene expression associated with bronchiectasis in nasal epithelium. ERJ Open Res. 2026 May; 12(3).View Related Profiles. PMID: 42094231; PMCID: PMC13139922; DOI: 10.1183/23120541.00814-2025;
     
  3. Ning B, Chiu DJ, Pfefferkorn RM, Cullinane E, Kefella Y, Kane E, Reyes-Ortiz V, Liu G, Zhang X, Liu H, Sultan L, Green E, Constant M, Spira AE, Campbell JD, Reid ME, Varelas X, Burks EJ, Lenburg ME, Mazzilli SA, Beane JE. Upregulation of an Epithelial miRNA Is Associated with Immune Evasion in Progressive Bronchial Premalignant Lesions. Cancer Immunol Res. 2026 Apr 02; 14(4):689-707.View Related Profiles. PMID: 41670462; PMCID: PMC12969512; DOI: 10.1158/2326-6066.CIR-25-0431;
     
  4. Steiner D, Sultan L, Sullivan T, Liu H, Xiao X, LeClerc A, Melvin S, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Suzuki K, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Vascular invasion-associated gene expression is detectable in pre-surgical biopsies of stage I lung adenocarcinoma. Nat Commun. 2026 Mar 24; 17(1).View Related Profiles. PMID: 41876493; PMCID: PMC13013712; DOI: 10.1038/s41467-026-70600-2;
     
  5. Okajima Y, Lenburg ME, Diaz AA. When asthmatic distal airways lose their identity: a new mechanism of mucus plugs pathogenesis. Am J Respir Crit Care Med. 2026 Feb 01; 212(2):197-198. PMID: 41738085; PMCID: PMC13003398; DOI: 10.1093/ajrccm/aamaf100;
     
  6. Souery WN, Billatos E, Elalami R, San José Estépar R, Cho MH, Diaz AA, Lenburg ME. Mucus plugs-associated gene expression identifies pathophysiology shared with chronic bronchitis. Am J Respir Crit Care Med. 2026 Feb 01; 212(2):253-267.View Related Profiles. PMID: 41072469; PMCID: PMC12560677; DOI: 10.1164/rccm.202501-0262OC;
     
  7. Anderson KE, Tran LM, Krysan K, Kefella Y, Yu L, Fishbein GA, Rodriguez E, Shabihkhani M, Stefanko DP, Green E, Liu G, Liu H, Zhang S, Kane E, Mehrad M, Spira AE, Dubinett SM, Burks EJ, Mazzilli SA, Lenburg ME, Beane JE. Archetype analysis of lung adenocarcinoma premalignancy links heterogeneity in premalignant lesions to diverging features of invasive disease. bioRxiv. 2025 Oct 06.View Related Profiles. PMID: 41278661; PMCID: PMC12632533; DOI: 10.1101/2025.10.04.680402;
     
  8. Ning B, Chiu DJ, Pfefferkorn RM, Kefella Y, Kane E, Reyes-Ortiz V, Liu G, Zhang S, Liu H, Sultan L, Green E, Constant M, Spira AE, Campbell JD, Reid ME, Varelas X, Burks EJ, Lenburg ME, Mazzilli SA, Beane JE. Epithelial miR-149-5p up-regulation is associated with immune evasion in progressive bronchial premalignant lesions. bioRxiv. 2025 Feb 05.View Related Profiles. PMID: 39975222; PMCID: PMC11838605; DOI: 10.1101/2025.02.03.636307;
     
  9. Steiner D, Sultan L, Sullivan T, Liu H, Zhang S, LeClerc A, Alekseyev YO, Liu G, Mazzilli SA, Zhang J, Rieger-Christ K, Burks EJ, Beane J, Lenburg ME. Identification of a gene expression signature of vascular invasion and recurrence in stage I lung adenocarcinoma via bulk and spatial transcriptomics. bioRxiv. 2024 Jun 10.View Related Profiles. PMID: 38915565; PMCID: PMC11195124; DOI: 10.1101/2024.06.07.597993;
     
  10. Steiner D, Park JA, Singh S, Potter A, Scalera J, Beane J, Suzuki K, Lenburg ME, Burks EJ. A computed tomography-based score indicative of lung cancer aggression (SILA) predicts lung adenocarcinomas with low malignant potential or vascular invasion. Cancer Biomark. 2025 Jan; 42(1):CBM230456.View Related Profiles. PMID: 39058440; PMCID: PMC12226792; DOI: 10.3233/CBM-230456;
     
Showing 10 of 212 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 212 publications over 29 distinct years, with a maximum of 22 publications in 2012

YearPublications
19921
19931
19942
19961
20011
20031
20041
20054
20063
20077
20088
200913
201013
201120
201222
201311
201416
201516
201615
201714
20183
20195
20205
20217
20225
20237
20242
20252
20266
Contact for Mentoring:

75 E. Newton St Evans Building
Boston MA 02118
Google Map


Lenburg's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department